Washington groups urge Congress to block OMB rule
Read, Watch or Listen
In Washington on July 13, 2026, a coalition of 57 patient advocacy organizations operating as "United for Cures" sent a joint letter to top congressional leaders urging them to halt a proposed Trump administration Office of Management and Budget rule. The draft "Regulation for Federal Financial Assistance" would mandate senior political appointee review of all federal grants and cooperative agreements, giving them authority to select recipients and terminate awards deemed misaligned with administration priorities. The groups warned it could destabilize biomedical research and invite political interference. The public comment period closed late Monday, with implementation targeted for October 1, 2026.
Prepared by Lauren Mitchell and reviewed by editorial team.
Timeline of Events
- July 13, 2026 Coalition sends joint congressional letter
- July 13, 2026 Public comment period officially closes
- July 13, 2026 Letter targets top congressional leaders
- July 13, 2026 Groups cite biomedical research destabilization risks
- July 13, 2026 OMB rule expands political grant oversight
- October 1, 2026 Proposed regulation scheduled to take effect
- 2027 Fiscal year Rule would govern federal assistance
- Future date Congress may consider blocking regulation
Why This Matters to You
This proposed rule could affect how federal funds are distributed. It could impact biomedical research, potentially slowing down new treatments or cures. If you or a loved one rely on medical advancements, this is worth watching.
The Bottom Line
The "United for Cures" coalition is pushing back against increased political control over federal grants. They're concerned about potential interference in research. Keep an eye on Congress' response. Worth forwarding if you know someone in the medical field.
Coverage of Story:
From Left
No left-leaning sources found for this story.
From Right
No right-leaning sources found for this story.
Comments